Hjem › Ikke-muskulinvasiv blærecancer › Texas › Dallas
Kliniske studier for Ikke-muskulinvasiv blærecancer i Dallas, TX
10 studier for Ikke-muskulinvasiv blærecancer søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
RekruttererFase 2
- Urology Clinics of North Texas, Dallas
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RekruttererFase 1
- Cancer Center Outpatient Building, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- UT Southwestern Medical Center - West Campus Building, Dallas
- og 2 flere
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
RekruttererObservasjonsstudie
- UT Southwestern Medical Center, Dallas
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
RekruttererFase 2
- UT Southwestern Medical Center, Dallas
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
RekruttererObservasjonsstudie
- University of Texas Southwestern Medical Center, Dallas
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekruttererFase 1
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruttererFase 1/2
- UT Southwestern Medical Center, Dallas
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
RekruttererObservasjonsstudie
- UT Southwestern Medical Center, Dallas
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
RekruttererFase 1/2
- University of Texas Southwestern Medical Center, Dallas
Blue Light Cystoscopy With Cysview® Registry
RekruttererObservasjonsstudie
- UT Southwestern, Dallas
Ikke-muskulinvasiv blærecancer-studier i andre byer
- Columbus, OH10 studier
- New York City, NY10 studier
- Myrtle Beach, SC9 studier
- Edison, NJ9 studier
- Baltimore, MD8 studier
- Nashville, TN8 studier
- Syracuse, NY8 studier
- Houston, TX7 studier
- Indianapolis, IN7 studier
- Philadelphia, PA7 studier
- Birmingham, AL7 studier
- Atlanta, GA7 studier
Andre studier i Dallas
- Brystkreft55 studier
- Ikke-småcellet lungekreft52 studier
- Metastatisk kreft42 studier
- Hjertesvikt42 studier
- Kreft (alle typer)37 studier
- Prostatakreft36 studier
- Kolorektal kreft33 studier
- Fedme30 studier
- Eggstokkreft28 studier
- Lungekreft27 studier
- Blærekreft27 studier
- Endometriekreft24 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.